Clinical determinants of ultrasound-guided sclerotherapy: Part II: In search of the ideal injectate volume

Dermatologic Surgery

Volumn 24, Issue 1, 1998, Pages 136-140

  Kanter, Alan ^a  

^a Vein Center of Orange County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRADECYL SULFATE SODIUM;

ADULT; AGED; CONTROLLED STUDY; DRUG SAFETY; ECHOGRAPHY; FEMALE; FEVER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECANALIZATION; REVIEW; SAPHENOUS VEIN; SCLEROTHERAPY; TREATMENT OUTCOME; VASOSPASM; VEIN INSUFFICIENCY;

EID: 0031913999     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1998.tb04066.x     Document Type: Review

References (7)

1. Kanter A, Thibault PK. Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy. Dermatol Surg 1996;22:648-52.
2. Zummo M, Forrestal M. Sclerotherapy of the long saphenous vein: a prospective duplex controlled comparative study. Phlebology 1995;(Suppl 1)571-3.
3. Kanter A. Clinical determinants of ultrasound-guided sclerotherapy outcome. Part I: The effects of age, gender, and vein size. Dermatol Surg 1997;24:131-135.
4. Beebe HG, Bergan JJ, Bergqvist D, et al. Classification and grading of chronic venous disease in the lower limbs: a consensus statement. Phlebology 1995;10:42-5.
5. Thibault PK. Duplex examination. Dermatol Surg 1995;21:77-82.
6. Fegan G. Varicose Veins. Compression Sclerotherapy. London: Heinemann Medical Books Ltd., 1967:67-8.
7. Klein JA. Tumescent technique for local anesthesia. West J Med 1996;164:517.